Valeant sees 'unrivaled' growth in possible Allergan merger

Mon Apr 21, 2014 5:37pm EDT

Related Topics

(Reuters) - A merger between Valeant Pharmaceuticals International Inc (VRX.TO) and Allergan Inc (AGN.N) would create an "unrivaled platform for growth and value creation" in the healthcare sector, a spokesperson for Valeant said on Monday.

Valeant will finalize and announce terms of its proposal shortly, the spokesperson said.

(Reporting by Rod Nickel. Editing by Andre Grenon)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.